Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats

References

• Algul D, Duman G, Ozdemir S, et al. (2018). Preformulation, characterization, and in vitro release studies of caffeine-loaded solid lipid nanoparticles. J Cosmet Sci 69:165–73.
   PubMed Web of Science ®Google Scholar
• Bakhaidar R, O’Neill S, Ramtoola Z. (2020). PLGA-PEG nanoparticles show minimal risks of interference with platelet function of human platelet-rich plasma. IJMS 21:9716.
   Web of Science ®Google Scholar
• Bian Q, Huang JH, Liang QQ, et al. (2011). The osteogenetic effect of astragaloside IV with centrifugating pressure on the OCT-1 cells. Pharmazie 66:63–8.
   PubMed Web of Science ®Google Scholar
• Cai J, Duan Y, Yu J, et al. (2012). Bone-targeting glycol and NSAIDS ester prodrugs of Rhein: synthesis, hydroxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies. Eur J Med Chem 55:409–19.
   PubMed Web of Science ®Google Scholar
• Cai M, Yang L, Zhang S, et al. (2017). A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy. Int J Nanomed 12:7469–82.
   PubMed Web of Science ®Google Scholar
• Cai Z, Wang Y, Zhu LJ, Liu ZQ. (2010). Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 11:197–207.
   PubMed Web of Science ®Google Scholar
• Chang Q, Geng R, Wang S, et al. (2016). DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting. Drug Deliv 23:3629–38.
   PubMed Web of Science ®Google Scholar
• Chen X, Peng LH, Shan YH, et al. (2013). Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. Int J Pharm 447:171–81.
   PubMed Web of Science ®Google Scholar
• Chen Z, Gu B. (2009). Enhanced oral bioavailability of Astragaloside IV in rats through complexation with 2-hydroxypropyl-beta-cyclodextrin. Asian J Pharm Sci 4:56–64.
   Google Scholar
• Chopin F, Biver E, Funck-Brentano T, et al. (2012). Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis. Joint Bone Spine 79:26–31.
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, De Angelis F, et al. (2015). Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. Eur J Pharm Biopharm 89:30–9.
   PubMed Web of Science ®Google Scholar
• Daman Z, Montazeri H, Azizi M, et al. (2015). Polymeric micelles of PEG-PLA copolymer as a carrier for salinomycin against gemcitabine-resistant pancreatic cancer. Pharm Res 32:3756–67.
   PubMed Web of Science ®Google Scholar
• Du YZ, Weng Q, Yuan H, Hu FQ. (2010). Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. Acs Nano 4:6894–902.
   PubMed Web of Science ®Google Scholar
• Effendy NM, Khamis MF, Shuid AN. (2017). The effects of Labisia pumila extracts on bone microarchitecture of ovariectomized-induced osteoporosis rats: a micro-CT analysis. J Xray Sci Technol 25:101–12.
   PubMed Web of Science ®Google Scholar
• Godfrin-Valnet M, Khan KA, Guillot X, et al. (2014). Sirtuin 1 activity in peripheral blood mononuclear cells of patients with osteoporosis. Med Sci Monit Basic Res 20:142–5.
   PubMedGoogle Scholar
• Gong YS, Chen J, Zhang QZ, Zhang JT. (2006). Effect of 17beta-oestradiol and ginsenoside on osteoporosis in ovariectomised rats. J Asian Nat Prod Res 8:649–56.
   PubMed Web of Science ®Google Scholar
• Grossen P, Witzigmann D, Sieber S, Huwyler J. (2017). PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application. J Control Release 260:46–60.
   PubMed Web of Science ®Google Scholar
• Guo LH, Cao Y, Zhuang RT, et al. (2019). Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway. Int J Mol Med 43:830–8.
   PubMed Web of Science ®Google Scholar
• Hasanpour A, Esmaeili F, Hosseini H, Amani A. (2021). Use of mPEG-PLGA nanoparticles to improve bioactivity and hemocompatibility of streptokinase: in-vitro and in-vivo studies. Mater Sci Eng C Mater Biol Appl 118:111427.
   PubMed Web of Science ®Google Scholar
• Jiang J, Li J, Zhang Z, et al. (2015). Mechanism of enhanced antiosteoporosis effect of circinal-icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate. IJN 10:2377–89.
   Web of Science ®Google Scholar
• Jiang T, Yu X, Carbone EJ, et al. (2014). Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Int J Pharm 475:547–57.
   PubMed Web of Science ®Google Scholar
• Katsumi H, Sano J, Nishikawa M, et al. (2015). Molecular design of bisphosphonate-modified proteins for efficient bone targeting in vivo. PLOS One 10:e0135966.
   PubMed Web of Science ®Google Scholar
• Kimble RB, Srivastava S, Ross FP, et al. (1996). Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271:28890–7.
   PubMed Web of Science ®Google Scholar
• Kraft JC, Freeling JP, Wang Z, Ho RJ. (2014). Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci 103:29–52.
   PubMed Web of Science ®Google Scholar
• Lehrskov LL, Kjeldsen S, Lyngbaek MP, et al. (2020). Interleukin-6 may not affect bone resorption marker CTX or bone formation marker P1NP in humans. J Endocr Soc 4:bvaa093.
   PubMed Web of Science ®Google Scholar
• Li M, Wang W, Geng L, et al. (2015). Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis. Int J Mol Med 36:1335–44.
   PubMed Web of Science ®Google Scholar
• Li XD, Wang JS, Chang B, et al. (2011). Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells. J Ethnopharmacol 134:268–74.
   PubMed Web of Science ®Google Scholar
• Ling T, Yu M, Weng W, et al. (2013). Improvement of drug elution in thin mineralized collagen coatings with PLGA-PEG-PLGA micelles. J Biomed Mater Res A 101:3256–65.
   PubMed Web of Science ®Google Scholar
• Liu WC, Yen JF, Lang CL, et al. (2013). Bisphophonates in CKD patients with low bone mineral density. ScientificWorldJournal 2013:837573.
   PubMed Web of Science ®Google Scholar
• Manabe N, Kirikoshi R, Takahashi O. (2015). Glycolic acid-catalyzed deamidation of asparagine residues in degrading PLGA matrices: a computational study. Int J Mol Sci 16:7261–72.
   PubMed Web of Science ®Google Scholar
• Maraka S, Kennel KA. (2015). Bisphosphonates for the prevention and treatment of osteoporosis. BMJ 351:h3783.
   PubMed Web of Science ®Google Scholar
• Ming LG, Zhou J, Cheng GZ, et al. (2011). Osthol, a coumarin isolated from common cnidium fruit, enhances the differentiation and maturation of osteoblasts in vitro. Pharmacology 88:33–43.
   PubMed Web of Science ®Google Scholar
• Neale JR, Richter NB, Merten KE, et al. (2009). Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent. Bioorg Med Chem Lett 19:680–3.
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. (2001). Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–41.
   PubMed Web of Science ®Google Scholar
• Nie M, Zhang Q, Zhang G, et al. (2017). Synthesis of resveratrol loaded mPEG-PLA nanomicelles for the prevention of osteoporosis in ovariectomized rats. Lat Am J Pharm 36:2112–9.
   Web of Science ®Google Scholar
• Niimi R, Kono T, Nishihara A, et al. (2014). Determinants associated with bone mineral density increase in response to daily teriparatide treatment in patients with osteoporosis. Bone 66:26–30.
   PubMed Web of Science ®Google Scholar
• Ong SG, Ming LC, Lee KS, Yuen KH. (2016). Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics 8:25.
   PubMed Web of Science ®Google Scholar
• Ou L, Wei P, Li M, Gao F. (2019). Inhibitory effect of Astragalus polysaccharide on osteoporosis in ovariectomized rats by regulating FoxO3a /Wnt signaling pathway. Acta Cir Bras 34:e201900502.
   PubMed Web of Science ®Google Scholar
• Pan H, Sima M, Kopecková P, et al. (2008). Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates. Mol Pharm 5:548–58.
   PubMed Web of Science ®Google Scholar
• Park H, Na K. (2013). Conjugation of the photosensitizer chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy. Biomaterials 34:6992–7000.
   PubMed Web of Science ®Google Scholar
• Pasut G, Veronese FM. (2009). PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev 61:1177–88.
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–27.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Köditz R, Pfohl M, Schatz H. (2002). Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23:90–119.
   PubMed Web of Science ®Google Scholar
• Pierce WM Jr, Waite LC. (1987). Bone-targeted carbonic anhydrase inhibitors: effect of a proinhibitor on bone resorption in vitro. Proc Soc Exp Biol Med 186:96–102.
   PubMed Web of Science ®Google Scholar
• Pignatello R, Cenni E, Micieli D, et al. (2009). A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. Nanomedicine 4:161–75.
   PubMed Web of Science ®Google Scholar
• Polymeri AA, Kodovazenitis GJ, Polymeris AD, Komboli M. (2015). Bisphosphonates: clinical applications and adverse events in dentistry. Oral Health Prev Dent 13:289–99.
   PubMed Web of Science ®Google Scholar
• Qing LS, Chen TB, Sun WX, et al. (2019). Pharmacokinetics comparison, intestinal absorption and acute toxicity assessment of a novel water-soluble astragaloside IV derivative (astragalosidic acid, LS-102). Eur J Drug Metab Pharmacokinet 44:251–9.
   PubMed Web of Science ®Google Scholar
• Rawat P, Ahmad I, Thomas SC, et al. (2016). Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: pharmacokinetic and biochemical assessment. Int J Pharm 506:253–61.
   PubMed Web of Science ®Google Scholar
• Shakir M, Jolly R, Khan MS, et al. (2015). Nano-hydroxyapatite/chitosan-starch nanocomposite as a novel bone construct: synthesis and in vitro studies. Int J Biol Macromol 80:282–92.
   PubMed Web of Science ®Google Scholar
• Song P, Du W, Li W, et al. (2020). Preparation, characterization, and in vitro evaluation of amphiphilic peptide P12 and P12-DOX nanomicelles as antitumor drug carriers. Nanomater Nanotechnol 10:184798042091151.
   Web of Science ®Google Scholar
• Suda T, Udagawa N, Nakamura I, et al. (1995). Modulation of osteoclast differentiation by local factors. Bone 17:87S–91.
   PubMed Web of Science ®Google Scholar
• Sun C, Li W, Ma P, et al. (2020a). Development of TPGS/F127/F68 mixed polymeric micelles: enhanced oral bioavailability and hepatoprotection of syringic acid against carbon tetrachloride-induced hepatotoxicity. Food Chem Toxicol 137:111126.
   PubMed Web of Science ®Google Scholar
• Sun NY, Liu XL, Gao J, et al. (2020b). Astragaloside-IV modulates NGF-induced osteoblast differentiation via the GSK3β/β-catenin signalling pathway. Mol Med Rep 23:1.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei J, Lyu J, et al. (2019). Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis. J Nanobiotechnol 17:10.
   PubMed Web of Science ®Google Scholar
• Udagawa N, Takahashi N, Yasuda H, et al. (2000). Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478–3484.
   PubMed Web of Science ®Google Scholar
• Wang D, Miller SC, Kopecková P, Kopecek J. (2005). Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev 57:1049–1076.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu J, Tao S, et al. (2015). Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Int J Nanomed 10:5671–5685.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang Q, Cao X, et al. (2018). Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles. Int J Pharm 550:24–34.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu M, Wang W, et al. (2019). Preparation and evaluation of mPEG-PLGA block copolymer micelles loaded with a sarsasapogenin derivative. AAPS PharmSciTech 20:280.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang ZP, Huang CY, et al. (2019). The neuropeptide vasoactive intestinal peptide levels in serum are inversely related to disease severity of postmenopausal osteoporosis: a cross-sectional study. Genet Test Mol Biomarkers 23:480–486.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie J, Ai Z, Su J. (2019). Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis. Int J Nanomed 14:7839–7849.
   PubMed Web of Science ®Google Scholar
• Wei L, Ke J, Prasadam I, et al. (2014). A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects. Osteoporos Int 25:2089–2096.
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu C, Huang H, et al. (2018). Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment. Drug Deliv Transl Res 8:1090–1102.
   PubMed Web of Science ®Google Scholar
• Xie YJ, Wang QL, Adu-Frimpong M, et al. (2019). Preparation and evaluation of isoliquiritigenin-loaded F127/P123 polymeric micelles. Drug Dev Ind Pharm 45:1224–1232.
   PubMed Web of Science ®Google Scholar
• Yao W, Xu P, Pang Z, et al. (2014). Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs. Int J Nanomed 9:3963–3970.
   PubMed Web of Science ®Google Scholar
• Ye WL, Zhao YP, Li HQ, et al. (2015). Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer. Sci Rep 5:14614.
   PubMed Web of Science ®Google Scholar
• Zhang K, Tang X, Zhang J, et al. (2014). PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications. J Control Release 183:77–86.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhu LL, Chen GG, Du Y. (2007). Pharmacokinetics of astragaloside iv in beagle dogs. Eur J Drug Metab Pharmacokinet 32:75–79.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cheng N, Miron R, et al. (2012). Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials 33:6698–6708.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng E, Xu Y, et al. (2015). Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Int J Clin Exp Med 8:16352–16357.
   PubMed Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. (2012). Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 97:101–108.
   PubMed Web of Science ®Google Scholar